{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-023246","form_type":"8-K","ticker":"SFES","cik":"0000086115","company_name":"SAFEGUARD SCIENTIFICS INC","filed_at":"2022-09-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.307787+00:00","generated_at":"2026-06-23T06:52:27.973448+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Safeguard Scientifics exits Lumesis via sale to SOLVE Advisors for $5.3M initial cash","bullets":["Safeguard received $5.3M initial cash proceeds from sale of Lumesis stake to SOLVE Advisors.","Additional cash may come from final net working capital adjustments and escrow contingencies.","Safeguard deployed $5.6M to Lumesis since 2012; expects to report a gain in Q3 2022.","CEO Eric Salzman highlighted progress on portfolio monetization for shareholders."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-023246","json":"https://secwatch.observer/filing/0001437749-22-023246.json","markdown":"https://secwatch.observer/filing/0001437749-22-023246.md","text":"https://secwatch.observer/filing/0001437749-22-023246.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/86115/000143774922023246/0001437749-22-023246-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/86115/000143774922023246/sfe20220929_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T06:52:27.973448+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}